Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshihiro Fujimura

Showing results (21-30 of 176) with videos related to

Pageof 18
Sort By:
Internal Medicine (Tokyo, Japan)|March 23, 2011
H1N1 influenza (swine flu)-associated thrombotic microangiopathy with a markedly high plasma ratio of von Willebrand factor to ADAMTS13Rui Akiyama, Isao Komori, Ryugo Hiramoto, et al.
International Journal of Hematology|February 15, 2002
Von Willebrand factor-cleaving protease and Upshaw-Schulman syndromeYoshihiro Fujimura, Masanori Matsumoto, Hideo Yagi, et al.
Thrombosis and Haemostasis|August 5, 2009
Heterogeneous pathogenic processes of thrombotic microangiopathies in patients with connective tissue diseasesTomomi Matsuyama, Masataka Kuwana, Masanori Matsumoto, et al.
Biochemistry|June 19, 2002
Binding site on human von Willebrand factor of bitiscetin, a snake venom-derived platelet aggregation inducerTaei Matsui, Jiharu Hamako, Tadashi Matsushita, et al.
International Journal of Hepatology|October 14, 2011
Determination of ADAMTS13 and Its Clinical Significance for ADAMTS13 Supplementation Therapy to Improve the Survival of Patients with Decompensated Liver CirrhosisMasahito Uemura, Yoshihiro Fujimura, Saiho Ko, et al.
The Journal of Obstetrics and Gynaecology Research|July 7, 2012
Autopsy case of sudden maternal death from thrombotic thrombocytopenic purpuraTakuma Yamamoto, Yoshihiro Fujimura, Yuko Emoto, et al.
Journal of Hepatology|February 16, 2005
Development of ADAMTS13 inhibitor in a patient with hepatitis C virus-related liver cirrhosis causes thrombotic thrombocytopenic purpuraMasato Yagita, Masahito Uemura, Takefumi Nakamura, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 5, 2014
[Recent therapeutic strategy for thrombotic thrombocytopenic purpura]Yoshihiro Fujimura, Masanori Matsumoto, Ayami Isonishi, et al.
Transfusion|April 9, 2013
ADAMTS13 unbound to larger von Willebrand factor multimers in cryosupernatant: implications for selection of plasma preparations for thrombotic thrombocytopenic purpura treatmentYuji Hori, Masaki Hayakawa, Ayami Isonishi, et al.
Thrombosis Research|October 13, 2006
Quantitative Western blot analysis of plasma ADAMTS13 antigen in patients with Upshaw-Schulman syndromeHiromichi Ishizashi, Hideo Yagi, Masanori Matsumoto, et al.
Pageof 18

Showing results (21-30 of 176) with videos related to

Sort By:
Pageof 18
Internal Medicine (Tokyo, Japan)|March 23, 2011
H1N1 influenza (swine flu)-associated thrombotic microangiopathy with a markedly high plasma ratio of von Willebrand factor to ADAMTS13Rui Akiyama, Isao Komori, Ryugo Hiramoto, et al.
International Journal of Hematology|February 15, 2002
Von Willebrand factor-cleaving protease and Upshaw-Schulman syndromeYoshihiro Fujimura, Masanori Matsumoto, Hideo Yagi, et al.
Thrombosis and Haemostasis|August 5, 2009
Heterogeneous pathogenic processes of thrombotic microangiopathies in patients with connective tissue diseasesTomomi Matsuyama, Masataka Kuwana, Masanori Matsumoto, et al.
Biochemistry|June 19, 2002
Binding site on human von Willebrand factor of bitiscetin, a snake venom-derived platelet aggregation inducerTaei Matsui, Jiharu Hamako, Tadashi Matsushita, et al.
International Journal of Hepatology|October 14, 2011
Determination of ADAMTS13 and Its Clinical Significance for ADAMTS13 Supplementation Therapy to Improve the Survival of Patients with Decompensated Liver CirrhosisMasahito Uemura, Yoshihiro Fujimura, Saiho Ko, et al.
The Journal of Obstetrics and Gynaecology Research|July 7, 2012
Autopsy case of sudden maternal death from thrombotic thrombocytopenic purpuraTakuma Yamamoto, Yoshihiro Fujimura, Yuko Emoto, et al.
Journal of Hepatology|February 16, 2005
Development of ADAMTS13 inhibitor in a patient with hepatitis C virus-related liver cirrhosis causes thrombotic thrombocytopenic purpuraMasato Yagita, Masahito Uemura, Takefumi Nakamura, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 5, 2014
[Recent therapeutic strategy for thrombotic thrombocytopenic purpura]Yoshihiro Fujimura, Masanori Matsumoto, Ayami Isonishi, et al.
Transfusion|April 9, 2013
ADAMTS13 unbound to larger von Willebrand factor multimers in cryosupernatant: implications for selection of plasma preparations for thrombotic thrombocytopenic purpura treatmentYuji Hori, Masaki Hayakawa, Ayami Isonishi, et al.
Thrombosis Research|October 13, 2006
Quantitative Western blot analysis of plasma ADAMTS13 antigen in patients with Upshaw-Schulman syndromeHiromichi Ishizashi, Hideo Yagi, Masanori Matsumoto, et al.
Pageof 18